Mannkind (MNKD) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.57% |
| Dec 31, 2025 | 41.17% |
| Sep 30, 2025 | 42.77% |
| Jun 30, 2025 | 39.38% |
| Mar 31, 2025 | 36.79% |
| Dec 31, 2024 | 27.79% |
| Sep 30, 2024 | -4.36% |
| Jun 30, 2024 | -7.15% |
| Mar 31, 2024 | -9.82% |
| Dec 31, 2023 | -10.91% |
| Sep 30, 2023 | -10.54% |
| Jun 30, 2023 | -13.17% |
| Mar 31, 2023 | -8.85% |
| Dec 31, 2022 | -9.56% |
| Sep 30, 2022 | -8.77% |
| Jun 30, 2022 | -8.02% |
| Mar 31, 2022 | -7.27% |
| Dec 31, 2021 | -6.14% |
| Sep 30, 2021 | 3.49% |
| Jun 30, 2021 | 3.87% |
| Mar 31, 2021 | 8.03% |
| Dec 31, 2020 | 5.64% |
| Sep 30, 2020 | 9.44% |
| Jun 30, 2020 | 6.70% |
| Mar 31, 2020 | 0.11% |
| Dec 31, 2019 | -1.24% |
| Sep 30, 2019 | 8.19% |
| Jun 30, 2019 | 18.84% |
| Mar 31, 2019 | 20.45% |
| Dec 31, 2018 | 20.64% |
| Sep 30, 2018 | -18.15% |
| Jun 30, 2018 | -21.40% |
| Mar 31, 2018 | -32.01% |
| Dec 31, 2017 | -42.78% |
| Sep 30, 2017 | -83.42% |
| Jun 30, 2017 | -68.34% |
| Mar 31, 2017 | -137.12% |
| Dec 31, 2016 | -81.49% |
| Sep 30, 2016 | -12.48% |
| Jun 30, 2016 | -34.00% |
| Mar 31, 2016 | -36.51% |
| Dec 31, 2015 | -46.83% |
| Sep 30, 2015 | 23.32% |
| Jun 30, 2015 | 22.11% |
| Mar 31, 2015 | 29.54% |
| Dec 31, 2014 | 38.27% |
| Sep 30, 2014 | 47.48% |
| Jun 30, 2014 | 42.61% |
| Dec 31, 2013 | 45.09% |